![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
Molecular Weight | 1028.5 g/mol |
---|---|
Molecular Formula | C44H56F2N6O12S2Zn+2 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 20 |
Rotatable Bond Count | 20 |
Exact Mass | 1026.265712 g/mol |
Monoisotopic Mass | 1026.265712 g/mol |
Topological Polar Surface Area | 299 A^2 |
Heavy Atom Count | 67 |
Formal Charge | 2 |
Complexity | 767 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Rosuvastatin zinc |
Active Ingredient | Rosuvastatin zinc |
Dosage Form | Tablet |
Route | oral |
Strength | 5mg; 10mg; 40mg; 20mg |
Market Status | Tentative Approval |
Company | Watson Labs |
2 of 2 | |
---|---|
Drug Name | Rosuvastatin zinc |
Active Ingredient | Rosuvastatin zinc |
Dosage Form | Tablet |
Route | oral |
Strength | 5mg; 10mg; 40mg; 20mg |
Market Status | Tentative Approval |
Company | Watson Labs |